Sign in
CompletedNo phase

Assessment of the Role of Probiotics in Prevention of Ventilator-Associated Pneumonia in Neonates

Key facts

Who runs it
Lamiaa Khaled Zidan
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
80 people enrolled
Started
1 May 2023
Ended
1 Jun 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Probiotic
Record updated
3 June 2025

Who can take part

Age
1 day to 28 days
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • All term neonates who required mechanical ventilation with ETT for more than 48 hours

Who cannot take part

  • Surgical causes of mechanical ventilation
  • Early-onset neonatal sepsis
  • Pre-existing pneumonia
  • A patient who was unfit for enteral intake
  • Prematurity <37 gestational weeks
  • Multiple congenital anomalies and suspected chromosomal anomalies

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Evaluate the preventive value of probiotics on VAP among ventilated neonates.

The 2 groups in the trial

  • Probiotic groupExisting treatment, for comparison

    40 ventilated neonates who received commercially available probiotics

    Treatment: Probiotic

  • Non-probiotic groupNo study treatment, for comparison

    40 ventilated neonates who only received the standard of care treatment

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
3 June 2025